Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
The classification of Artesunate Tablet includes Monoaromatic Artesunate and Compound Artesunate.
Artesunate Tablet is application in Hospital, Clinic and Other institution. The most of Artesunate Tablet is used in Hospital, and the market share of that is about 57 % in 2018.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 78% in 2017.
According to this study, over the next five years the Artesunate Tablet market will register a 7.1% CAGR in terms of revenue, the global market size will reach US$ 180 million by 2024, from US$ 130 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artesunate Tablet business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Artesunate Tablet market by product type, application, key manufacturers and key regions and countries.
This study considers the Artesunate Tablet value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Monoaromatic Artesunate
Compound Artesunate
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Artesunate Tablet consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Artesunate Tablet market by identifying its various subsegments.
Focuses on the key global Artesunate Tablet manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Artesunate Tablet with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Artesunate Tablet submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
